| Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine—a PDE1 inhibitor R Deshmukh, V Sharma, S Mehan, N Sharma, KL Bedi European journal of pharmacology, Elsevier 620 (1-3), 49-56, 2009 | 246 | 2009 |
| JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer’s and various neurodegenerative abnormalities S Mehan, H Meena, D Sharma, R Sankhla Journal of Molecular Neuroscience, Springer 43 (3), 376-390, 2011 | 182 | 2011 |
| Understanding multifactorial architecture of Parkinson’s disease: pathophysiology to management R Kaur, S Mehan, S Singh Neurological Sciences, Springer 40 (1), 13-23, 2019 | 93 | 2019 |
| Targeting PI3K-AKT/mTOR signaling in the prevention of Autism A Sharma, S Mehan Neurochemistry International, Elsevier, 105067, 2021 | 77 | 2021 |
| Hyperlipidemia: An updated review G Amit, S Vandana, M Sidharth Inter J of Biopharma & Toxicol Res 1 (1), 81-89, 2011 | 63 | 2011 |
| Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: Insights from behavioral and biochemical evidence R Sharma, S Rahi, S Mehan Toxicology reports, Elsevier 6, 1164-1175, 2019 | 60 | 2019 |
| Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme … S Mehan, V Monga, M Rani, R Dudi, K Ghimire Indian journal of pharmacology, Wolters Kluwer-Medknow 50 (6), 309, 2018 | 56 | 2018 |
| Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disorders S Mehan, S Parveen, S Kalra Neural Regeneration Research, Wolters Kluwer-Medknow 12 (2), 290, 2017 | 52 | 2017 |
| Neuroprotective Effect of α-Mangostin in the Ameliorating Propionic Acid-Induced Experimental Model of Autism in Wistar Rats A Tiwari, R Khera, S Rahi, S Mehan, HA Makeen, YH Khormi, ... Brain Sciences, MDPI 11, 288, 2021 | 45 | 2021 |
| Adenylate cyclase activator forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats S Mehan, S Rahi, A Tiwari, T Kapoor, K Rajdev, R Sharma, H Khera, ... Neural Regeneration Research, Wolters Kluwer-Medknow 15 (6), 1140, 2020 | 45 | 2020 |
| Neuroprotective effect of ellagic acid against chronically scopolamine induced Alzheimer’s type memory and cognitive dysfunctions: Possible behavioural and biochemical evidences R Kaur, S Parveen, S Mehan, D Khanna, S Kalra Int. J. Preven. Med. Res 1 (2), 45-64, 2015 | 44 | 2015 |
| Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats K Rajdev, EM Siddiqui, KS Jadaun, S Mehan IBRO Reports, Elsevier 8, 101-114, 2020 | 43 | 2020 |
| Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats. K Rajdev, EM Siddiqui, KS Jadaun, S Mehan IBRO Reports, Elsevier 8, 101-114, 2020 | 43 | 2020 |
| Understanding Acquired Brain Injury: A Review L Goldman, S Mehan, R Sharma, S Budkin, SN Kumar, A Sahu, M Kumar, ... Biomedicines, MDPI 10 (9), 2167, 2022 | 41 | 2022 |
| Nrf2/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALS E Minj, S Upadhayay, S Mehan Neurochemical Research, Springer, 1-18, 2021 | 41 | 2021 |
| Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological … N Kumar, N Sharma, R Khera, R Gupta, S Mehan Metabolic Brain Disease, Springer 36 (5), 911-925, 2021 | 41 | 2021 |
| Design, synthesis and neuropharmacological evaluation of new 2, 4-disubstituted-1, 5-benzodiazepines as CNS active agents R Verma, R Bhatia, G Singh, B Kumar, S Mehan, V Monga Bioorganic Chemistry, Elsevier 101, 104010, 2020 | 32 | 2020 |
| Smo-Shh signaling activator purmorphamine ameliorates neurobehavioral, molecular, and morphological alterations in an intracerebroventricular propionic acid-induced … S Rahi, R Gupta, A Sharma, S Mehan Human & Experimental Toxicology, SAGE, 09603271211013456, 2021 | 31 | 2021 |
| Understanding abnormal SMO-SHH signaling in autism spectrum disorder: potential drug target and therapeutic goals S Rahi, S Mehan Cellular and Molecular Neurobiology, Springer, 1-23, 2020 | 31 | 2020 |
| Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism R Khera, S Mehan, S Bhalla, S Kumar, A Alshammari, M Alharbi, ... Molecules, MDPI 27, 889, 2022 | 30 | 2022 |
